This case was reported by a healthcare professional and described the 
occurrence of dental cavity in a 5-year-old male patient who received 
Fluticasone propionate (Flovent) hfa-cfc free inhaler for asthma. 
The patient's past medical history included asthma. Concurrent medications 
included salbutamol sulphate (Albuterol) and Dallergy. 
Print Time: 18-JUL-2014 02:07 PM If a field is blank. there is no data for that field Page 109 of 328 
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information 
On 12 August 2012 the patient started Fluticasone propionate (inhaled) at 2 
puff(s) twice per day, Approximately 87 days later, on 7 November 2012, the 
patient experienced dental cavity. Treatment with Fluticasone propionate was 
continued. At the time of reporting, the event was unresolved. The health 
professional considered the event was unrelated to treatment with Fluticasone 
propionate. 
Physician assistant reports that a mom contacted her reporting that dentist 
stated her son's cavities, a total of four across six teeth, were due to her 
son's Flovent use. She doesn't believe that is the case but seeking if any 
issues have been reported. She wasn't able to provide specifics on when 
these may have started, but the dental appointment took place on 07 November 
2012. The child utilizes an inhaler with a spacer and is instructed to rinse 
mouth after each dose.